Company Registration No. 14327803 (England and Wales)
Weymouth Pharma Ltd
Unaudited accounts
for the year ended 31 August 2025
Weymouth Pharma Ltd
Unaudited accounts
Contents
Weymouth Pharma Ltd
Company Information
for the year ended 31 August 2025
Directors
Sunil Varghese Chacko
Moyosoreoluwa Ogunfowoke
Company Number
14327803 (England and Wales)
Registered Office
Weymouth Pharmacy
26 Abbotsbury Road
Weymouth
Dorset
DT4 0AE
England
Weymouth Pharma Ltd
Statement of financial position
as at 31 August 2025
Intangible assets
612,391
625,080
Tangible assets
3,173
3,966
Cash at bank and in hand
111,915
27,363
Creditors: amounts falling due within one year
(474,519)
(439,954)
Net current liabilities
(159,137)
(169,709)
Total assets less current liabilities
456,427
459,337
Creditors: amounts falling due after more than one year
(428,288)
(458,000)
Called up share capital
100
100
Profit and loss account
28,039
1,237
Shareholders' funds
28,139
1,337
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 2 May 2026 and were signed on its behalf by
Sunil Varghese Chacko
Director
Company Registration No. 14327803
Weymouth Pharma Ltd
Notes to the Accounts
for the year ended 31 August 2025
Weymouth Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14327803. The registered office is Weymouth Pharmacy, 26 Abbotsbury Road, Weymouth, Dorset, DT4 0AE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% reduce balance basis
4
Intangible fixed assets
Goodwill
At 1 September 2024
634,434
Charge for the year
12,689
Weymouth Pharma Ltd
Notes to the Accounts
for the year ended 31 August 2025
5
Tangible fixed assets
Computer equipment
Amounts falling due within one year
Trade debtors
126,005
112,915
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
30,000
30,000
Trade creditors
186,866
153,002
Taxes and social security
13,829
2,335
Other creditors
12,771
14,856
Loans from directors
231,053
239,761
8
Creditors: amounts falling due after more than one year
2025
2024
Bank loans
428,288
458,000
9
Average number of employees
During the year the average number of employees was 10 (2024: 14).